Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients (Q38206273)

31 August 2017

title

Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients (English)

1 reference

31 August 2017

0 references

1

John R Benson

1 reference

31 August 2017

Ismail Jatoi

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

4

1 reference

31 August 2017

page(s)

577-586

1 reference

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Management of the axilla in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Axillary Ultrasound and Fine-Needle Aspiration in the Preoperative Evaluation of the Breast Cancer Patient: An Algorithm Based on Tumor Size and Lymph Node Appearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: pros and cons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Axillary recurrence after sentinel node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.231

21 January 2018

Identifiers

DOI

10.2217/FON.13.231

1 reference

31 August 2017

1 reference